X
Alnylam’s Anant Murthy on making it as a US biotech in Europe
https://pharmaphorum.com/r-d/views-analysis-r-d/alnylam-anant-murthy-on-making-it-as-a-us-biotech-in-europe/
EU
EC to update IP rules to benefit generic exports
The European Commission (EC) is proposing to adjust intellectual property (IP) rules to help Europe’s pharma companies tap into fast-growing global markets.
Clinical trial lay summaries: a clearer picture emerges
EC wants pharma to make clinical trial results more patient-friendly.
Diabetes ‘lab-on-chip’ start-up gets €2M EU cash
Money comes from Horizon 2020 fund.
1 2